SELECT B — Selectimmune Pharma AB Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- SEK41.38m
- SEK35.54m
Brief: Lonza Collaborates With Selectimmune Collaborates To Develop Immunotherapeutic Drug Candidate
Brief: Selectimmune Pharma Q2 Pretax Loss Widens To SEK 3.1 Mln
Brief: Selectimmune Pharma Q1 Pretax Loss Narrows To SEK 2.2 Million
Brief: Selectimmune Pharma Signs Deal On Phase II Study For Infection Treatment
Brief: SelectImmune Pharma Announces Patent Granted For IRF7 Inhibitors Case
Brief: Selectimmune Q4 Loss After Tax Narrows To SEK 1.1 Million
Brief: Selectimmune Pharma Appoints Ann Gidner As New CEO
Brief: Selectimmune Pharma Q3 Pretax Loss Widens To SEK 2.4 Mln
Brief: Selectimmune Pharma Changes CEO
Brief: Selectimmune Pharma: Results From Clinical Study With IL-1 Receptor Inhibitors
Brief: Selectimmune: Positive Study Results
Brief: Selectimmune Pharma Announces Preliminary Results From New Pre-Clinical Study